Time-dose factor (TDF) analysis of dose rate effects in permanent implant dosimetry.
Orton CG, Webber BM.
Int J Radiat Oncol Biol Phys. 1977 Jan-Feb;2(1-2):55-60. doi: 10.1016/0360-3016(77)90008-6.
Time, dose and fractionation factor as an indicator of fibrosis of the abdominopelvic subcutaneous tissue.
Lederman MV, Faria SL, Malzyner A, Vizeu DM.
Int J Radiat Oncol Biol Phys. 1982 Aug;8(8):1447-8. doi: 10.1016/0360-3016(82)90598-3.
Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix.
Yudelev M, Kuten A, Tatcher M, Rubinov R, Karmeli R, Cohen Y, Robinson E.
Gynecol Oncol. 1986 Mar;23(3):310-5. doi: 10.1016/0090-8258(86)90131-9.
On the problem of time, dose and fractionation (TDF) in the linear-quadratic model.
Ulmer W.
Strahlentherapie. 1985 Mar;161(3):177-85.
Volume correction factor in time dose relationships in brachytherapy.
Supe SJ, Sasane JB, Gupta MK.
Strahlenther Onkol. 1987 May;163(5):309-13.
Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
Rao DV, Howell RW.
J Nucl Med. 1993 Oct;34(10):1801-10.
Dependence of tolerance dose on irradiated volume in radiotherapy, and determination of volume corrected time, dose and fractionation factors.
Gupta MK, Ajayi DO.
Clin Radiol. 1982 Nov;33(6):615-20. doi: 10.1016/s0009-9260(82)80382-6.
Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
Maruyama Y, Wierzbicki J.
Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1561-8. doi: 10.1016/0360-3016(90)90373-r.
[Relationship between central recurrence and time-dose factors in patients with carcinoma of uterine cervix after radiotherapy].
Gao JZ.
Zhonghua Zhong Liu Za Zhi. 1989 Sep;11(5):394-7.
[Practical use of the TDF factor in radiotherapy of basalioma and squamous cell carcinoma].
Bahmer FA.
Hautarzt. 1992 Oct;43(10):625-8.
